KardiaAI

KardiaAI is a software analysis library intended to assess ambulatory ECG rhythms in adult patients by providing a suite of algorithmic tools for noise filtering, heart rate reporting, and detailed arrhythmia detection. It functions as an integrated API within compatible ECG devices, offering capabilities like atrial fibrillation, bradycardia, tachycardia, and various sinus rhythm classifications to support clinical assessment.

KardiaAI is a software analysis library designed for integration into other medical device software to assess ambulatory electrocardiogram (ECG) rhythms from adult subjects under physician care. Its primary purpose is to analyze ECG data recorded from compatible ambulatory devices, providing functions such as ECG noise filtering, heart rate measurement, and detection of noisy ECG segments. The library is not intended for life-supporting systems, ECG monitors with cardiac alarms, over-the-counter use, or for patients with implanted electronic devices like pacemakers or ICDs. It functions as an Application Program Interface (API) library that target devices incorporate to enable algorithmic ECG analysis. The KardiaAI library offers several analytical capabilities, including reporting ECG rhythm analysis for the presence of sinus rhythm (further classifiable as normal, with wide QRS, with premature ventricular contractions (PVC), or with supraventricular ectopy), atrial fibrillation, bradycardia, and tachycardia. It also detects QRS complexes, classifies individual beats as PVC or non-PVC for ECGs in sinus rhythm, and generates an average beat from an ECG. Nonclinical testing, including algorithm performance assessment using proprietary and ANSI/AAMI EC57 databases, demonstrated that KardiaAI meets its performance specifications. Human factors usability studies confirmed users can understand its outputs and appropriate actions.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. What specific algorithms are used for each reported ECG rhythm analysis (e.g., atrial fibrillation, PVC detection), and what are their validated sensitivity and specificity in diverse adult populations?; How does the KardiaAI library handle ECG artifacts or varying signal quality from different compatible ambulatory ECG devices, and what is the impact on analysis accuracy?; What are the performance characteristics of the 'sinus rhythm with wide QRS' and 'sinus rhythm with supraventricular ectopy' detection features, particularly in distinguishing them from other arrhythmias?; Can the 'average beat' generation feature be customized or used for more advanced morphological analysis beyond PVC/non-PVC classification in sinus rhythm?; What are the integration requirements and API specifications for incorporating KardiaAI into third-party or new AliveCor devices, and how does it ensure data integrity and security during processing?